BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8913491)

  • 1. The surface properties of chemically synthesized peptides analogous to human pulmonary surfactant protein SP-C.
    Takei T; Hashimoto Y; Aiba T; Sakai K; Fujiwara T
    Biol Pharm Bull; 1996 Oct; 19(10):1247-53. PubMed ID: 8913491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of poly-leucine substituted analogues of the human surfactant protein SP-C.
    Takei T; Hashimoto Y; Ohtsubo E; Sakai K; Ohkawa H
    Biol Pharm Bull; 1996 Dec; 19(12):1550-5. PubMed ID: 8996637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Combination of Short and Simple Surfactant Protein B and C Analogues as a New Synthetic Surfactant: In Vitro and Animal Experiments.
    Choi YS; Chung SH; Bae CW
    Yonsei Med J; 2017 Jul; 58(4):823-828. PubMed ID: 28540997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, purification and surface activities of the human pulmonary surfactant protein-C (SP-C) analogue, SP-CL16 (6-28).
    Otsubo E; Takei T; Nomura M
    Biol Pharm Bull; 2001 Dec; 24(12):1362-5. PubMed ID: 11767102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of hydrophobic apoproteins as constituents of clinical exogenous surfactants.
    Hall SB; Venkitaraman AR; Whitsett JA; Holm BA; Notter RH
    Am Rev Respir Dis; 1992 Jan; 145(1):24-30. PubMed ID: 1731593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic peptide-containing surfactants--evaluation of transmembrane versus amphipathic helices and surfactant protein C poly-valyl to poly-leucyl substitution.
    Nilsson G; Gustafsson M; Vandenbussche G; Veldhuizen E; Griffiths WJ; Sjövall J; Haagsman HP; Ruysschaert JM; Robertson B; Curstedt T; Johansson J
    Eur J Biochem; 1998 Jul; 255(1):116-24. PubMed ID: 9692909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein composition of synthetic surfactant affects gas exchange in surfactant-deficient rats.
    Walther FJ; Hernández-Juviel J; Bruni R; Waring AJ
    Pediatr Res; 1998 May; 43(5):666-73. PubMed ID: 9585014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic mimics of surfactant proteins B and C: in vitro surface activity and effects on lung compliance in two animal models of surfactant deficiency.
    Bruni R; Hernández-Juviel JM; Tanoviceanu R; Walther FJ
    Mol Genet Metab; 1998 Feb; 63(2):116-25. PubMed ID: 9562965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biophysical activity of an artificial surfactant containing an analogue of surfactant protein (SP)-C and native SP-B.
    Palmblad M; Johansson J; Robertson B; Curstedt T
    Biochem J; 1999 Apr; 339 ( Pt 2)(Pt 2):381-6. PubMed ID: 10191270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the human pulmonary surfactant protein-C (SP-C), SP-CL16(6-28) on surface activities of surfactants with various phospholipids.
    Otsubo E; Takei T
    Biol Pharm Bull; 2002 Oct; 25(10):1303-6. PubMed ID: 12392083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biophysical and biological activity of a synthetic 8.7-kDa hydrophobic pulmonary surfactant protein SP-B.
    Sarin VK; Gupta S; Leung TK; Taylor VE; Ohning BL; Whitsett JA; Fox JL
    Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2633-7. PubMed ID: 2320580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a Synthetic Surfactant Using a Surfactant Protein-C Peptide Analog: In Vitro Studies of Surface Physical Properties.
    Bae CW; Chung SH; Choi YS
    Yonsei Med J; 2016 Jan; 57(1):203-8. PubMed ID: 26632402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acylation of pulmonary surfactant protein-C is required for its optimal surface active interactions with phospholipids.
    Wang Z; Gurel O; Baatz JE; Notter RH
    J Biol Chem; 1996 Aug; 271(32):19104-9. PubMed ID: 8702584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of surface properties and physiological effects of a synthetic and a natural surfactant in preterm rabbits.
    Corcoran JD; Berggren P; Sun B; Halliday HL; Robertson B; Curstedt T
    Arch Dis Child Fetal Neonatal Ed; 1994 Nov; 71(3):F165-9. PubMed ID: 7820710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationships between biophysical activity and the secondary structure of synthetic peptides from the pulmonary surfactant protein SP-B.
    Kang JH; Lee MK; Kim KL; Hahm KS
    Biochem Mol Biol Int; 1996 Oct; 40(3):617-27. PubMed ID: 8908373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of mixtures of surfactant lipids and synthetic sequences of surfactant proteins SP-B and SP-C.
    Amirkhanian JD; Bruni R; Waring AJ; Taeusch HW
    Biochim Biophys Acta; 1991 Jun; 1096(4):355-60. PubMed ID: 2065107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of synthetic peptides in the formation of biophysically and biologically active pulmonary surfactants.
    Revak SD; Merritt TA; Hallman M; Heldt G; La Polla RJ; Hoey K; Houghten RA; Cochrane CG
    Pediatr Res; 1991 May; 29(5):460-5. PubMed ID: 1896249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Palmitoylation of a pulmonary surfactant protein C analogue affects the surface associated lipid reservoir and film stability.
    Gustafsson M; Palmblad M; Curstedt T; Johansson J; Schürch S
    Biochim Biophys Acta; 2000 Jun; 1466(1-2):169-78. PubMed ID: 10825440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-molecular-weight hydrophobic proteins from bovine pulmonary surfactant.
    Mathialagan N; Possmayer F
    Biochim Biophys Acta; 1990 Jul; 1045(2):121-7. PubMed ID: 2378907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of bovine pulmonary surfactant-associated proteins in the surface-active property of phospholipid mixtures.
    Yu SH; Possmayer F
    Biochim Biophys Acta; 1990 Oct; 1046(3):233-41. PubMed ID: 2223863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.